EarningsQ2 2023 Earnings Report

Mirum Pharmaceuticals (08D) Q2 2023 Earnings Report

1 Followers

DE:08D Q2 2023 EPS Results

Actual EPS-€1.74

Consensus EPS-€0.71

Beat/MissMissed by -€1.03

One Year Ago EPS-€0.75

Actual Revenue€33.57M

Expected Revenue€27.26M

Beat/MissBeat by +€6.31M

YoY Revenue Growth+114.46%

QuarterQ2 2023

Date08/03/2023

TimeAfter Close

Conference CallThursday, August 3, 2023

DE:08D Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

DE:08D Q2 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-0.44 / -	0.045	―
Aug 05, 2026	2026 (Q2)	-0.67 / -0.95	-0.107	-783.33% (-0.84)
May 06, 2026	2026 (Q1)	-0.33 / -12.02	-0.269	-4376.67% (-11.76)
Feb 25, 2026	2025 (Q4)	0.05 / -0.09	-0.439	79.59% (+0.35)
Nov 04, 2025	2025 (Q3)	-0.13 / 0.04	-0.269	116.67% (+0.31)
Aug 06, 2025	2025 (Q2)	-0.29 / -0.11	-0.466	76.92% (+0.36)
May 07, 2025	2025 (Q1)	-0.30 / -0.27	-0.483	44.44% (+0.21)
Feb 26, 2025	2024 (Q4)	-0.23 / -0.44	-0.564	22.22% (+0.13)
Nov 12, 2024	2024 (Q3)	-0.40 / -0.27	-0.51	47.37% (+0.24)
Aug 07, 2024	2024 (Q2)	-0.42 / -0.47	-1.737	73.20% (+1.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed